CN
239-364-2
应用筛选条件
关键词:'239-364-2'
显示 1-30 共 31 条结果 关于 "239-364-2" 范围 技术文档
Product Information Sheet - SAE0118
References
1. Dougherty, W.G. et.al., Virology, 171(2),
356-364 (1989).
2. Cesaratto, F. et al., J. Biotech., 231(10),
239-249 (2016).
3. Kapust, R.B. et.al., Biochem. Biophys. Res
XP725 Antibody Number-Lot Number 071M4826
260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1 289 290 291 292 313 314 315 316 337 338 339 340 361 362 363 364
4.2 293 294 295
Product Information Sheet - T0523
and Katz, J.H., J. Clin. Invest., 42(3),
314-326 (1963).
10. Finch, C., et al., Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M., J. Biol.
Chem., 268(12), 8521-8528 (1993
Product Information Sheet - T0178
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T6011
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T6013
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T2036
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T8158
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T3309
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T1408
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T1283
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T2252
1963).
10. Finch, C. et al., Effect of transfused reticulocytes on
iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T4132
1963).
10. Finch, C. et al., Effect of transfused reticulocytes on
iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T4382
1963).
10. Finch, C. et al., Effect of transfused reticulocytes on
iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T5391
1963).
10. Finch, C. et al., Effect of transfused reticulocytes on
iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
holo-Transferrin human (T0665) - Product Information Sheet
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Data Sheet - T0665
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R.S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
Product Information Sheet - T1147
1963).
10. Finch, C., et al., Effect of transfused reticulocytes
on iron exchange. Blood, 59(2), 364-369 (1982).
11. Inman, R. S., and Wessling-Resnick, M.,
Characterization of transferrin-independent
XP725 Antibody List Lot 129K4831
M NP_004955.2 y y n/d
323 HDAC-2 H3159 3066 HDAC2 P NP_001518.3 y y n/d
324 HDAC-2 H2663 3066 HDAC2 M NP_001518.3 y y y
362 HMG-1 H9537 3146 HMGB1 M NP_002119.1 y y y
364 hnRNP-A1 R4528 3178 HNRNPA1 M NP
XP725 Antibody List Lot 129K4830
M NP_004955.2 y y n/d
323 HDAC-2 H3159 3066 HDAC2 P NP_001518.3 y y n/d
324 HDAC-2 H2663 3066 HDAC2 M NP_001518.3 y y y
362 HMG-1 H9537 3146 HMGB1 M NP_002119.1 y y y
364 hnRNP-A1 R4528 3178 HNRNPA1 M NP
XP725 Antibody List Lot 089K4791
M NP_004955.2 y y n/d
323 HDAC-2 H3159 3066 HDAC2 P NP_001518.3 y y n/d
324 HDAC-2 H2663 3066 HDAC2 M NP_001518.3 y y y
362 HMG-1 H9537 3146 HMGB1 M NP_002119.1 y y y
364 hnRNP-A1 R4528 3178 HNRNPA1 M NP
TB534 WideScreenﾙ BeadPlexﾙ Phospho-EGFR Profiling Panel 9-Plex Complete Assay Kit
PMA stim
A431
Vanadate / H2O2
control
peptide
n= 5 5 5 5 5
MFI 41 58 280 364 62
St Dev 4 4 26 36 10
% CV 8.9 7.7 9.4 9.8 16.3
Bioreactor Systems for Bone Tissue Engineering
Warnke, P.H., et al. Growth and transplantation of a cus-
tom vascularised bone graft in a man. Lancet 364, 766, 2004.
157. Warnke, P.H., et al. Man as living bioreactor: fate of an
exogenously prepared
List of Antibodies
SUV39H1 Histone Methyl Transferase S8316 M y y n/d
362 HMG-1 H9537 M y y y
363 hMps1 M5818 M y n/d n/d
364 hnRNP-A1 R4528 M y y y
365 hnRNP-A1 R9778 M y n/d n/d
366 hnRNP-A2/B1 R4653 M y y y
367 hnRNP-C1/C2
3D BIOPRINTING: Printing a Brighter Future
Lo, W.; Tsavaris, A.; Peng, D.; Lipson, H.; Bonassar, L. Tissue
Eng. Part C Methods 2011, 17 (2), 239–248.
(33) Shelby, T.; Li, J.; Alizadeh, H. V.; Yang, Y. P. Development and
Characterization of
3D BIOPRINTING: Printing a Brighter Future
Lo, W.; Tsavaris, A.; Peng, D.; Lipson, H.; Bonassar, L. Tissue
Eng. Part C Methods 2011, 17 (2), 239–248.
(33) Shelby, T.; Li, J.; Alizadeh, H. V.; Yang, Y. P. Development and
Characterization of
XP725 Antibody List
HMGB1 NP_002119.1,NP_034569.1,NP_037095.1 M y y y
363 hMps1 M5818 7272 TTK NP_003309.2 M y n/d n/d
364 hnRNP-A1 R4528 3178, 15382, 29578 HNRPA1,Hnrpa1 NP_112420.1,NP_034577.1,NP_058944.1 M y y y
365 hnRNP-A1
XP725 Antibody List 013M4793
HMGB1 NP_002119.1,NP_034569.1,NP_037095.1 M y y y
363 hMps1 M5818 7272 TTK NP_003309.2 M y n/d n/d
364 hnRNP-A1 R4528 3178, 15382, 29578 HNRPA1,Hnrpa1 NP_112420.1,NP_034577.1,NP_058944.1 M y y y
365 hnRNP-A1
Halal Certificate
SOLUTION 20 WT. % IN H2O W205303 A31891 HC-23SID964
363. AMYL ACETATE W504009 C44277 HC-23SI1K83
364. AMYL BUTYRATE MIXTURE OF ISOMERS, 98%, FG W205915 B21391 HC-23SIYN01
365. AMYL FORMATE 95%, FG
Halal Certificate
SOLUTION 20 WT. % IN H2O W205303 A31891 HC-22SI1N85
363. AMYL ACETATE W504009 C44277 HC-22SIIX05
364. AMYL BUTYRATE MIXTURE OF ISOMERS, 98%, FG W205915 B21391 HC-22SI8H22
365. AMYL FORMATE 95%, FG
1/2